Agilon Health Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $5.9B-2.3% YoYTTM through 30 Jun 2026
Net Income -$232.2MTTM through 30 Jun 2026
Free Cash Flow -$85MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 4.6% |
| EBITDA Margin | -4.8% |
| Operating Margin | 0.3% |
| Net Margin | -3.9% |
Returns
27.0%ROE
-24.8%ROA
Balance Sheet Health
Debt / Equity0.17x
Current Ratio1.04x
Net Debt-$271Mnet cash position
Cash & Equivalents$107.2M
Quality Metrics
Altman Z-Score2.12
Piotroski F-Score5 / 9
FCF Margin-1.4%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $5.9B
Diluted EPSFY2025: $-0.95
Dividend
No dividend
Capital Allocation
Capex Intensity0.2%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.